Select Page

In January 2020, Sapphire Biotech, Inc., acquiree of AXIM Biotechnologies, signed an agreement with Skysong Innovations establishing license rights to pharmaceutical materials and methods for cancer treatment. Such a development is a win in the fight against cancer and for the federal legalization of cannabis.

 

READ THE FULL ARTICLE